ClearPoint Neuro (CLPT) Receivables (2011 - 2026)

ClearPoint Neuro (CLPT) has 16 years of Receivables data on file, last reported at $9.4 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 151.59% year-over-year to $9.4 million; the trailing twelve-month figure through Mar 2026 stood at $9.4 million (up 151.59% YoY), and the FY2025 full-year result was $6.7 million, up 42.14% from the prior year.
• Receivables rose to $9.4 million in Q1 2026, from $6.7 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $9.4 million in Q1 2026 to a low of $2.3 million in Q1 2022.
• A 5-year average of $4.2 million and a median of $3.8 million in 2025 frame the typical range for Receivables.
• Across the five-year window, Receivables slipped 16.4% in 2023 and jumped 151.59% in 2026, its largest moves.
• Tracing CLPT's Receivables over 5 years: stood at $3.0 million in 2022, then soared by 31.82% to $3.9 million in 2023, then advanced by 19.5% to $4.7 million in 2024, then jumped by 42.14% to $6.7 million in 2025, then surged by 40.87% to $9.4 million in 2026.
• Business Quant data shows CLPT's Receivables at $9.4 million in Q1 2026, $6.7 million in Q4 2025, and $5.3 million in Q3 2025.